Search by Drug Name or NDC
NDC 65162-0253-50 Ranitidine 150 mg/1 Details
Ranitidine 150 mg/1
Ranitidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
| NDC | 65162-0253 |
|---|---|
| Product ID | 65162-253_3f730b87-2405-485e-a562-ff56320cac69 |
| Associated GPIs | 49200020100305 |
| GCN Sequence Number | 011673 |
| GCN Sequence Number Description | ranitidine HCl TABLET 150 MG ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 10200 |
| HICL Sequence Number | 004520 |
| HICL Sequence Number Description | RANITIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ranitidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ranitidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077824 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0253-50 (65162025350)
| NDC Package Code | 65162-253-50 |
|---|---|
| Billing NDC | 65162025350 |
| Package | 500 TABLET in 1 BOTTLE (65162-253-50) |
| Marketing Start Date | 2009-12-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |